SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001610618-23-000024
Filing Date
2023-03-23
Accepted
2023-03-23 16:01:25
Documents
5
Effectiveness Date
2023-03-23
Reference 429
333-263350

Document Format Files

Seq Description Document Type Size
1 FORM S-8 cdtxs-82023x03x23.htm S-8 57071
2 CALCULATION OF FILING FEE TABLES exhibit1072023-03x23.htm EX-FILING FEES 20577
3 CONSENT OF COOLEY LLP exhibit512023-03x23.htm EX-5.1 11445
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM exhibit2312023-03x23.htm EX-23.1 2200
5 GRAPHIC cooleylogo.jpg GRAPHIC 38052
  Complete submission text file 0001610618-23-000024.txt   143326
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270781 | Film No.: 23756124
SIC: 2836 Biological Products, (No Diagnostic Substances)